Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma.

Attalla, Kyrollis; Weng, Stanley; Voss, Martin H; Hakimi, A Ari

Attalla, Kyrollis; Weng, Stanley; Voss, Martin H; Hakimi, A Ari.

Afiliação

Attalla K; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, 353 East 68th Street, 5th Floor, New York, NY 10065, USA.
Weng S; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, 353 East 68th Street, 5th Floor, New York, NY 10065, USA.
Voss MH; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, 353 East 68th Street, 5th Floor, New York, NY 10065, USA.
Hakimi AA; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, 353 East 68th Street, 5th Floor, New York, NY 10065, USA. Electronic address: hakimia@mskcc.org.

Urol Clin North Am ; 47(3): 293-303, 2020 Aug.

Article em En | MEDLINE | ID: mdl-32600532

Assuntos

Antineoplásicos Imunológicos/uso terapêutico; Carcinoma de Células Renais/epidemiologia; Neoplasias Renais/epidemiologia; Biomarcadores/análise; Carcinoma de Células Renais/metabolismo; Humanos; Imunoterapia; Neoplasias Renais/metabolismo; Prognóstico; Medição de Risco

Palavras-chave

Immunotherapy; Metastatic renal cell carcinoma; Predictive biomarker; Prognostic biomarker; Risk assessment; Targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Imunológicos / Neoplasias Renais Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google